NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

6-K - Haoxi Health Technology Ltd

Filed: 2026-04-22 AccNo: 0001213900-26-046610 Size: 5 MB
发布时间04/22 20:15 UTC
首次发现04/22 20:26 UTC
热度105.2
重要度66
情绪0.00

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 856 字符

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001213900-26-046610

Filing Date: 2026-04-22

Accepted: 2026-04-22 16:15:31

Documents: 77

Period of Report: 2025-12-31

Haoxi Health Technology Ltd (Filer) CIK : 0001954594 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 0630 Type: 6-K | Act: 34 | File No.: 001-41933 | Film No.: 26883979 SIC : 7311 Services-Advertising Agencies (CF Office: 07 Trade & Services)

1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0287058-6k_haoxi.htm iXBRL | 6-K

2 | UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED D | ea028705801ex99-1.htm iXBRL | EX-99.1

3 | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA | ea028705801ex99-2.htm | EX-99.2

9 | GRAPHIC | ea028705801_ex99-1img1.jpg | GRAPHIC